• ForwardForward
  • PrintPrint
  • Find EmployeesFind Employees
  • Find CompetitorsFind Competitors

Amyris Biotechnologies Inc

5980 Horton Street Ste. 350
Emeryville, California 94608
United States 
Website:  www.amyrisbiotech.com
Phone:  (510) 450-0761
Fax:  (510) 450-0794
Amyris Biotechnologies's profile was created using:
  • 433 online sources
-

Summary

Industry:  Pharmaceuticals, Biotechnology

Description
Amyris Biotechnologies is dedicated to improving the world by leveraging breakthroughs in synthetic biology. Amyris' technology is able to provide a consistent, cost-effective supply of biofuels and other high-value natural compounds, including pharmaceuticals, fine chemicals, and nutraceuticals.

Amyris is currently focused on two major projects:

-

Additional Resources

Find More Jobs

Job Openings

Senior Grants Accountant
San Francisco , CA

Senior Grants Accountant
Emeryville , CA

Senior Corporate Counsel
San Francisco , CA

Senior Corporate Counsel
Emeryville , CA


View More Statistics

Site Statistics

Monthly Unique Visitors: 370
Site Rank: 2,489,633
Trust Rating: Neutral
Stats by Compete.com

News Archive
Publication No. WO/2009/134946 Published on Nov. 5, Assigned to Amyris Biotechnologies for Fuel Composition (American Inventor)
US Fed News Service, Including US State News; 11/9/2009
...an amorphane or a stereoisomer thereof and methods of making and using same. The patent has been assigned to Amyris Biotechnologies Inc., Emeryville, Calif. According to an abstract posted by the World Intellectual Property Organization... ...more

Patent No. 7,592,295 Issued on Sept. 22, Assigned to Amyris Biotechnologies for Farnesene Dimer (California Inventors)
US Fed News Service, Including US State News; 10/5/2009
...The inventors were issued U.S. Patent No. 7,592,295 on Sept. 22. The patent has been assigned to Amyris Biotechnologies Inc., Emeryville, Calif. According to the abstract released by the U.S. Patent & Trademark Office... ...more

Publication No. WO/2009/126623 Published on Oct. 15, Assigned to Amyris Biotechnologies for Heterologous Sequences Expression (American Inventors)
US Fed News Service, Including US State News; 10/20/2009
...both of the U.S., have developed a expression of heterologous sequences. The patent has been assigned to Amyris Biotechnologies Inc., Emeryville, Calif. According to an abstract posted by the World Intellectual Property Organization... ...more

Powered By:

-

Key People

-

Competitors

About Thumbshots thumbnails

Copyright © 2009 Zoom Information Inc. All rights reserved.

BBeachHead-2009-12-03_RC001.1 OM17